Status:
COMPLETED
Effect of D-cycloserine on Treatment of Posttraumatic Stress Disorder (PTSD) in Youth
Lead Sponsor:
Tulane University School of Medicine
Collaborating Sponsors:
National Institute of Mental Health (NIMH)
Conditions:
Posttraumatic Stress Disorders
PTSD
Eligibility:
All Genders
7-12 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to show whether D-cycloserine in combination with cognitive behavioral therapy (CBT) is more effective than CBT plus placebo to reduce symptoms of posttraumatic stress dis...
Detailed Description
While most individuals with PTSD treated with cognitive behavioral therapy (CBT) show improvement, they still have some enduring symptoms and functional impairment. Accordingly, there is a need for tr...
Eligibility Criteria
Inclusion
- Certain number of PTSD symptoms plus functional impairment
- Must be able to swallow pills
Exclusion
- Serious kidney or liver disease
- Epilepsy
- Bipolar
- Psychosis
Key Trial Info
Start Date :
June 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2012
Estimated Enrollment :
33 Patients enrolled
Trial Details
Trial ID
NCT01157416
Start Date
June 1 2010
End Date
June 1 2012
Last Update
April 21 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tulane University Health Sciences Center, 1440 Canal St.
New Orleans, Louisiana, United States, 70112